Benenden Health and Weight Loss Injections: The Misconception Worth Clearing Up

The Benenden myth: why cash-plan members often come here looking for injections

Benenden Health is a health cash plan, not a clinical prescriber. It reimburses costs for certain procedures and consultations, but prescription medicines for weight management sit outside what cash-plan-style membership typically covers. That distinction trips up a lot of people who reasonably assume their health plan will extend to newer weight loss treatments.

The reason this matters practically is that Mounjaro and Wegovy are prescription-only medicines (POMs). UK law requires a clinical assessment before any prescriber can issue a prescription for them. No insurer, scheme or membership can short-circuit that requirement, and no legitimate pharmacy will supply these medicines to someone who has not been assessed. If a seller is offering GLP-1 injections without that step, the MHRA has warned repeatedly that counterfeit pens are circulating in exactly this space, some containing insulin rather than the labelled medicine. You can report suspect sellers through the MHRA's Yellow Card scheme.

So the practical path for anyone who came here through a Benenden search is this: the clinical route is what matters, not the insurer. A regulated online pharmacy with its own GPhC-registered prescribers is often the fastest legitimate option, particularly if NHS waiting lists are long or you do not yet meet the NHS's phased eligibility criteria.

Which weight loss injections are actually licensed in the UK right now

There are two. Mounjaro (tirzepatide, made by Eli Lilly) and Wegovy (semaglutide, made by Novo Nordisk) are the only injectable medicines licensed specifically for weight management in adults in the UK at the time of writing. Both are once-weekly subcutaneous injections that you administer yourself, typically into the abdomen, thigh or upper arm, rotating the site each week.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, the only one of its kind licensed for weight loss in the UK. It activates two appetite-regulating pathways rather than one, which is reflected in its trial results. Semaglutide is a GLP-1 receptor agonist that works along a single pathway. Both medicines slow gastric emptying, increase the sensation of fullness, and reduce appetite, helping people eat less without relying on willpower alone. A useful overview of how these medicines work is available on the NHS medicines page for tirzepatide.

A note on medicines you may have heard of: Ozempic is also semaglutide, but it holds a licence only for type 2 diabetes, not weight management. Saxenda (liraglutide) is licensed for weight management but is an older, daily injection; nume does not dispense it. If you want to read about the other weight loss injections that exist and where they sit, that page covers the wider landscape. For the two medicines at the centre of most conversations right now, the weight loss injections overview is a good starting point.

Who these injections are licensed for, and what a prescriber actually looks at

The licensed eligibility criteria for private treatment are set by the medicines' authorisations. Adults with a BMI of 30 or above qualify, as do adults with a BMI of 27 or above who have at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnoea or osteoarthritis. For some ethnic backgrounds, UK guidance applies thresholds 2.5 kg/m² lower. The NHS BMI calculator is a quick way to check where you stand before a consultation.

BMI alone is not the whole story. A prescriber also looks at your medical history, current medicines, and any contraindications before issuing a prescription. Certain conditions (a history of medullary thyroid carcinoma, some gastrointestinal conditions, or a previous episode of pancreatitis) would prompt careful clinical discussion. Pregnancy, breastfeeding, and actively trying to conceive are situations where these medicines are not recommended, and they are not licensed for anyone under 18. These are the details a prescriber works through with you, not a checklist you self-complete and post.

NICE recommended tirzepatide for NHS use in December 2024 (TA1026), with access being phased in over several cohorts by BMI and number of qualifying conditions. If you are curious about how the health benefits of weight loss injections compare across the two medicines, that page sets out the evidence alongside the broader clinical picture. The benefits of weight loss injections page covers the wider evidence on what sustained weight reduction tends to mean for related health conditions.

What the clinical and safety picture actually looks like day-to-day

The most common side effects with both medicines are gastrointestinal: nausea, loose stools, constipation, indigestion, and occasional vomiting. These tend to be most noticeable in the first weeks of treatment or after a dose increase, and they settle for most people as the body adjusts. Starting at the lowest dose and titrating slowly is specifically designed to make this manageable, it is why the schedule exists, not an arbitrary formality.

There are side effects to take seriously. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but potentially serious risk: severe stomach pain that does not pass and may spread to the back, with or without vomiting, warrants urgent medical attention. Other signs that need prompt review include significant dehydration from prolonged vomiting, signs of an allergic reaction, or gallbladder symptoms. Your prescriber and the Patient Information Leaflet that comes with your treatment are the right places to look for a full list.

On the practicalities of actually using the injection: each Mounjaro KwikPen contains four weekly doses, stored in the fridge between 2°C and 8°C. When a pen arrives from a regulated pharmacy, it comes via DPD in a plain, unbranded box with a thermal liner, nothing on the outside says what it is. Tracking arrives on your phone the morning of delivery. The pen itself is compact and pre-loaded; no drawing up, no measuring. Disposing of used pens safely matters: a sharps container is the correct method, and your local council or pharmacy will collect it.

For anyone weighing up the cost side of private treatment, the cost context page on weight loss injections explains what the UK price landscape looks like, what legitimate treatment actually includes, and why the cheapest listing is usually the wrong place to start. If you are also wondering whether these medicines can support weight loss specifically, the page on the benefits of B12 injections for weight loss is worth reading alongside the broader look at weight loss treatment options if you want to understand the full range before deciding anything.

If you are ready to find out whether you are clinically suitable, start your free consultation with a GPhC-registered prescriber who will review your answers the same day.